Perspective Therapeutics CATX Deferred income
Deferred income at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeNoncurrent.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's deferred income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's deferred income?
- Perspective Therapeutics (CATX) reported deferred income of $26.6M in Q1 2026.
- How has Perspective Therapeutics's deferred income changed year-over-year?
- Perspective Therapeutics's deferred income decreased by 0.0% year-over-year, from $26.6M to $26.6M.
- What does deferred income mean?
- Deferred income represents payments received from customers or partners for goods or services that have not yet been earned or delivered. In the context of a radiopharmaceutical company, this often relates to long-term collaboration agreements, milestone payments, or upfront licensing fees that are recognized as revenue over time. This metric provides insight into the company's future revenue pipeline and the timing of performance obligation fulfillment.